Chloroprocaine vs prilocaine for spinal anaesthesia in day-case surgery: a double-blind randomized trial

Chloroprocaine vs prilocaine for spinal anaesthesia in day-case surgery: a double-blind randomized trial - SPACE (SPinal Anesthetics Chloroprocaine prilocainE)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON44965

Enrollment

150

Registered

2016-02-29

Start date

2016-11-25

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal anaesthesia

Interventions

Patients receive intrathecally 40 mg plain chloroprocaine or 40 mg hyperbaric prilocaine.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Scheduled ambulatory knee arthroscopy - Age >18 years - ASA physical status I- II

Exclusion criteria

Exclusion criteria: - Allergy to one of the study drugs - Contraindication to neuraxial anaesthesia - Previous neuropathy to the lower extremities - Pregnancy

Design outcomes

Primary

Measure	Time frame
The time to complete motor block recovery	—

Secondary

Measure	Time frame
Urine retention needing catheterisation and Transient Neurologic Syndrom (TNS).	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)